In particular, these include statements relating to future actions; prospective changes in raw material costs, product pricing or product demand; future performance; estimated capital expenditures; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of contingencies such as legal proceedings and environmental liabilities; and financial results. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, mark-to-market adjustments associated with benefit plans, environmental remediation costs, acquisition-related costs, and other non-routine costs. Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 28 EV / 2023E EBITDA Historic Multiple 6.5 8.3 9.5 13.8 12.7 12.6 11.3 8.7 18.6 16.5 10.1 10.0 9.7 9.5 9.4 8.7 01 1) 01 8) 02 3) Avient Specialty Other Specialty / SEGMENT DATA U.S. & Canada 40% 37% 18% 2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Building and END MARKET REVENUE $2,355M $402M $1,300M $272M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $592M$3,653M (1) 9% 30 (1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs 2022 REVENUE | $2 .4 B ILL ION 34% 38% END MARKET REGION 31 34% 21% Building & 1% Energy 2% COLOR, ADDITIVES & INKS 2022 PRO FORMA REVENUE | $1 .3 B ILL ION 52% 35% 32 19% 8%Industrial 16% 9% Defense Building & END MARKET REGION SPECIALTY ENGINEERED MATERIALS 32% 27% 14% Building & 3% 1% Defense 1% (18% of sales) 9% 2022 PROFORMA AVIENT REGIONAL SALES 27% 14% 17% Building & (37% of sales)Transportation 12% Building & US & Canada (40% of sales) 7% 56% 23% 7% Building & 1% LATAM (5% of sales) 3% 33 BY END MARKET Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

In particular, these include statements relating to future actions; prospective changes in raw material costs, product pricing or product demand; future performance; estimated capital expenditures; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of contingencies such as legal proceedings and environmental liabilities; and financial results. GUIDANCE DEBT / LEVERAGE REDUCTION • Completed sale of Distribution and paid down $750M of debt in November • Strong free cash flow in fourth quarter reduced leverage and enabled paydown of additional $200M of debt • Fixed/Floating Debt Ratio 63/37 • Proven track record of deleveraging following acquisitions through consistent free cash flow generation $725 $725 $725 $575 $500 $400 $600 $525 $425 $650 $650 $650 $600 $2.40B $2.20B 2030 Notes 2029 Term Loan 2026 Term Loan 2025 Notes After Distribution Divestiture Year-End 8 Year-End Leverage 3.8x 3.1x 2.9x 2023 Notes After Avient Protective Materials Acquisition $3.15B 2022 TRANSFORMATIONAL PORTFOLIO ENHANCEMENTS 9 EBITDA margins expanded from 12% to 16% Diversified end markets with reduced exposure to more cyclical industries Dyneema® Acquisition $1.48B acquisition strengthens composites platform Significantly improved EBITDA margins $950M divestiture results in 100% specialty sales Strong exit multiple of 10x TTM EBITDA despite market volatility Distribution Divestiture Improved Portfolio GROWING COMPOSITES PLATFORM CONTRIBUTIONS TO SEM SEGMENT 10 Note: 2022 is pro forma for Avient Protective Materials 2016 Sales 2022 Sales Advanced Composites 51% $560M $1,300M Advanced Composites COMPOSITES PORTFOLIO D Y N E E M A ® E X P A N D S O U R E N G I N E E R E D F I B E R S A N D T A P E S T E C H N O L O G Y LFT Tapes Laminates/Panels Shapes Pultrusion Engineered Fibers 11 ADVANCED COMPOSITES PERFORMANCE 12 (1) Pro forma for the acquisition of Avient Protective Materials $51 $84 $212 $668 $4 $10 $41 $169 (1) (1) PORTFOLIO EVOLUTION AND EPS EXPANSION 13 Adj. Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 32 EV / 2023E EBITDA Historic Multiple 6.5 8.3 10.0 15.6 13.9 13.7 12.8 9.5 18.0 17.5 12.3 10.2 9.7 8.8 8.4 5.9 (2 01 1) (2 01 8) RA W M AT ER IA L OVE RV IE W 34 RAW MATERIAL 2022 ANNUAL PURCHASES Performance Additives 16% Pigments TiO2 Dyestuffs 2% Polyethylene Nylon Polypropylene Styrenic Block Copolymer Other Raw Materials 30% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials Excludes Avient Protective Materials SEGMENT DATA U.S. & Canada 40% 37% 18% Latin America 2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Building and END MARKET REVENUE (1) Total company adjusted EBITDA of $592M includes corporate costs $2,355M $402M $1,300M $272M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $592M$3,653M 36 C O L O R , A D D I T I V E S & I N K S 2022 REVENUE | $2 .4 B ILL ION US & Canada 34% 38% Latin America END MARKET REGION 37 34% 21% Building & 1% Energy 2% S P E C I A LT Y E N G I N E E R E D M AT E R I A L S 2022 PRO FORMA REVENUE | $1 .3 B ILL ION END MARKET US & Canada 52% 35% REGION 38 19% 8%Industrial 16% Building & 32% 27% 14% Building & 3% 1% Defense 1% (18% of sales) 2022 PROFORMA AVIENT REGIONAL SALES BY END MARKET 27% 14% 17% Building & (37% of sales)Transportation Building & US & Canada (40% of sales) 7% 56% 23% 7% Building & 1% LATAM (5% of sales) 3% 39

a wholly-owned subsidiary of Avient Corporation NAME BASE RESIN(S) AVAILABLE FEATURES1 Trilliant™ ABS, LCP, PA, PC, ABS, PA 6, PA 66, PC/ABS, PC/PSU, PEBA, PEEK, PES, POM, PPA, PSU Certified to USP Class VI Formulations locked down Drug master file submissions by product stewardship Pre-colored, small lot production down to 50 lb–250 lb Sterilization, chemical resistance, and secondary process guidance Adherence to FDM-GMP manufacturing standards Antimicrobial technologies Materials for radiation shielding protection NEU™ Specialty Materials2 PEBA, TPU, PA 11, PA 12, PP, PE, TPE Radiopacifiers, stabilizers, and surface modifiers Antimicrobial technologies Pre-colored formulations Small lot capabilities Short lead times Versaflex™ HC TPE Overmolding Clear and heat resistant Ultra clear grades Ultra soft TPE gels, 30 shore OO FDA, USP Class VI, ISO 10993 approved grades Sterilizable under autoclave, radiation, and EtO gas HEALTHCARE SPECIALTY THERMOPLASTICS reSound™ R Recycled Formulations PA6, PA66, PC Transportation, Consumer, Household Appliance, Electrical & Electronics, PA grades: Up to 100% recycled content PC grades: Up to 70% recycled content PIR and PCR grades available Support the circular economy Comparable performance to prime grades Customizable solution Surround™ ABS, PP, PBT, PC, PA 66 Transportation, Electrical Integrated EMI/RFI shielding Long fiber technology Conductive properties Galvanic corrosion protection Lightweighting and ease of processing Stat-Tech™ ABS, PA, PC, PC/ABS, PC/PSU, PEEK, PEI, PES, PP, PPA Transportation, Electrical Integrated EMI/RFI shielding Conductive properties Anti-static/dissipative properties Corrosion resistance Lightweighting and ease of processing Clean room materials for semiconductors available Therma-Tech™ LCP, PA, PEEK, PP, PPA, PPS Consumer, Transportation Thermally conductive Low coefficient of thermal expansion SPECIALTY ENGINEERED THERMOPLASTICS Barricade™ Elastomers with Fortrex™ Technology Barricade™ high-performance elastomers bring next genera- tion technology to market to bridge the gap between tradi- tional TPEs and silicone Healthcare, Industrial Aerospace, Appliances, Electronics High temperature compression set Processes on thermoplastic injection molding and extrusion equipment Customizable and colorable Process simplicity CROSSLINKABLE ELASTOMERS Barricade formulations leverage licensed Fortrex™ technology. NAME DESCRIPTION TARGET MARKETS AVAILABLE FEATURES1 OnFlex™ Part of Avient’s portfolio of specialty TPEs, OnFlex materials are designed to meet and withstand the rigor and durability of various industrial applications. SPECIALTY ENGINEERED MATERIALS FOCUS MARKETS The Specialty Engineered Materials product portfolio offers customized solutions to serve a full range of markets, including: Specialty Consumer Transportation Specialty Packaging Healthcare Building & Construction Electrical & Electronics Appliance Wire & Cable 1.844.4AVIENT www.avient.com Copyright © 2020, Avient Corporation.

Speed to market is essential today, and Avient plays a crucial role in our customers’ success. From technology portfolios to end markets to geographies and distribution channels, this acquisition made perfect sense. We will do so though our investments and focus on sustainable solutions for high-growth markets, including healthcare, consumer, packaging and composites/5G.

Does your colorant meet all the regulatory requirements of your intended market? Streamlining this process and being able to react quickly and cost-effectively to market dynamics can give that all-important competitive edge. Rapid color development Accelerated color match, development and delivery for rapid market access.

Does your colorant meet all the regulatory requirements of your intended market? Streamlining this process and being able to react quickly and cost-effectively to market dynamics can give that all-important competitive edge. Rapid color development Accelerated color match, development and delivery for rapid market access.

Competitive Market Pay Information. Exercise or Base Price of Option Awards (column (i)) Grant Date Fair Value of Stock and Option Awards (column (j)) Narrative Disclosure Relating to the 2018 Summary Compensation Table and the 2018 Grants of Plan-Based Awards Table Outstanding Equity Awards at 2018 Fiscal Year-End Exercise Price Expiration Date Market Value of Shares or Units of Stock That Have Not Vested Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights that Have Not Vested (j) Stock Awards Equity Incentive Plan Awards: Number of Securities Underlying Unearned Options Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that Have Not Vested (i) Number of Shares or Units of Stock That Have Not Vested Number of Underlying Unexercised Options (#) Unexercisable Number of Securities Underlying Options (#) Exercisable Option Awards Number of Securities Underlying Unexercised Options (#) Exercisable (column (b)) Number of Securities Underlying Unexercised Options (#) Unexercisable (column (c)) Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (column (d)) Option Exercise Price (column (e)) Option Expiration Date (column (f)) Number of Shares or Units of Stock That Have Not Vested (column (g)) Market Value of Shares or Units of Stock That Have Not Vested (column (h)) Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (column (i)) Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested (column (j)) 2018 Option Exercises and Stock Vested Option Awards Stock Awards Acquired on Exercise Value Realized on Exercise Acquired on Vesting Value Realized on Vesting Option Awards (columns (b) and (c)) Stock Awards (columns (d) and (e)) 2018 Nonqualified Deferred Compensation Aggregate Executive Registrant Aggregate Aggregate Aggregate Balance at Contributions Contributions Earnings Withdrawals/ Balance at in Last FY in Last FY in Last FY Distributions Last FYE (1) ($)(2) ($)(3) ($)(4) ($) ($)(1)(5) Potential Payments Upon Termination or Change of Control Summary of Potential Payments Management Continuity Agreements Executive Severance Plan Annual Plan Long-Term Incentive Awards Retirement Benefits Payments and Benefits Upon Termination — As of the End of Fiscal Year 2018 CEO Pay Ratio Disclosure CEO Annual Total Compensation for 2018: $6,127,920 Median Employee Annual Total Compensation for 2018: $48,056 Ratio of CEO to Median Employee Annual Total Compensation for 2018: 128:1 How the Median Employee was Determined in 2017 Compensation Committee Interlocks and Insider Participation Policy on Related Person Transactions Risk Assessment of the Compensation Programs Compensation Committee Report The Compensation Committee of the Board of Directors MISCELLANEOUS MISCELLANEOUS PROVISIONS Voting at the Meeting not Shareholder Proposals MISCELLANEOUS Proxy Solicitation We will furnish without charge to each person from whom a proxy is being solicited, upon written request of any such person, a copy of the Annual Report on Form 10-K of the Company for the fiscal year ending December 31, 2018, as filed with the SEC, including the financial statements and schedules thereto.

As a result, although the Compensation Committee includes market data and its general understanding of current compensation practices in the market in the overall mix of facff tors it considers in assessing Named Executive Officff er compensation, it does not target specific market levels. Market Value of Shares or Units of Stock That Have Not Vested (column (h)) The market value is determined based on the closing stock price of our common shares on December 30, 2016 ($32.04). If there is no regular public trading market for the Common Shares, the Market Value per Share of the Common Shares shall be the faiff r market value of the Common Shares as determined in good faith by the Compensation Committee.

In particular, these include statements relating to future actions; prospective changes in raw material costs, product pricing or product demand; future performance; estimated capital expenditures; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of contingencies such as legal proceedings and environmental liabilities; and financial results. Source: Peer data per Bloomberg market data as of April 21, 2022 86 82 86 86 84 78 77 89 86 81 80 76 76 76 67 67 11 (12) P PM AV VR 18% 16% 15% 15% 14% 14% 28% 28% 26% 22% 21% 19% 9% 9% T od ay P AV PM C VR Median: 21%Median: 15% 2022 EBITDA MARGINS VS. Financials are pro forma for the acquisition of Dyneema® and potential divestiture of Distribution Avient Specialty Other Specialty / Chemical Companies 45 Source: Peer data per Bloomberg market data as of April 21, 2022 Total Enterprise Value / NTM EBITDA With the Dyneema and Clariant Color business acquisition and divestment of the PP&S business, along with the proposed sale of our Distribution business, our exposure is now concentrated in less-cyclical and high-growth markets.

In particular, these include statements relating to future actions; prospective changes in raw material costs, product pricing or product demand; future performance; estimated capital expenditures; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of contingencies such as legal proceedings and environmental liabilities; and financial results. $86 $123 $0.53 $0.89 Q1 2021 – ORGANIC PERFORMANCE 3 Sales Adjusted Operating Income $991 $1,162 + 17% + 43% + 68% (1) (1) (1) Q1 2021 SEGMENT PERFORMANCE 4 CAI $536 $609 ($ in millions) SEM Distribution $64 $89 +14% +39% $290 $363 $19 $24 +25% +26% $185 $217 $22 $34 +17% +55% SPECIALTY EBITDA MARGIN EXPANSION 5 CAI (1) 2018-2020 financial information is pro forma to include a full year of Clariant Masterbatch business acquisition 15.3% 15.2% 16.2% 19.1% 2018 2019 2020 Q1 2021 14.8% 15.2% 17.6% 19.4% 2018 2019 2020 Q1 2021 SEM • Continued portfolio transformation to high-growth end markets and sustainable solutions • Clariant Masterbatch synergy realization • Investments in composites and outdoor high performance applications drive growth and mix improvements CAI EBITDA MARGIN EXPANSION 6 Legacy CAI 18.9% 18.9% 21.0% 2019 2020 Q1 2021 Legacy 11.9% 13.8% 17.4% 2019 2020 Q1 2021 • Early synergy capture translating to the bottom line • Positive mix with growth in healthcare, consumer and packaging end-markets • World-class vitality index of 36% represents sales from products introduced in the last five years. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 20 Avient reflects 2021 estimated EBITDA of $560M OUR VALUATION VERSUS PEERS Avient Specialty Other 10.2 17.7 16.0 14.9 14.6 11.6 11.1 26.7 24.0 22.8 14.3 12.7 11.5 11.2 11.1 11.0 10.3 10.1 9.5 9.4 8.3 7.0 Median: 11.1xMedian: 14.8x SUMMARY: WHY INVEST IN AVIENT?